Navigation Links
Watson's Generic Fentora® Receives FDA Approval
Date:1/10/2011

MORRISTOWN, N.J., Jan. 10, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for Fentanyl Buccal tablets, USP, in the 0.1, 0.2, 0.4, 0.6 and 0.8 mg strengths, the generic equivalent to Cephalon's Fentora ® tablets.

Watson's Abbreviated New Drug Application (ANDA) for its generic version of FENTORA® is the first generic application approved by FDA, and as such, may be entitled to a 180-day period of market exclusivity.  FDA will make a formal determination concerning Watson's entitlement to market exclusivity only in the event another Paragraph IV ANDA becomes eligible for final approval prior to 180 days after Watson's product launch or the expiration of listed Orange Book patents.  A decision on Cephalon's lawsuit alleging that Watson's product infringes various Cephalon patents remains pending in the U.S. District Court for the District of Delaware.  Watson is currently enjoined from launching its product until a decision is rendered.

Fentora ® had total U.S. sales of approximately $179 million for the twelve months ending November 30, 2010, according to IMS Health.  Fentanyl Buccal tablets are indicated to treat breakthrough pain in adult patients with cancer (18 years of age and older) who are regularly using other opioid pain medicines around-the-clock for their constant cancer pain.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is a leading global specialty pharmaceutical company.  The Company is engaged in the development and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health.  Watson has operations in many of the world's establishe
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
2. Watson Launches Generic Biaxin(R) XL
3. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
4. Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms
5. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
6. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
7. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
8. Bundling Two Generic Low-Cost Heart Drugs Prevents Heart Attack and Stroke in Large, Diverse Population, Observational Clinical Study Shows
9. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
10. Perrigo Confirms Filing for Generic Version of Mens Rogaine(R) Foam
11. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... WORTH, Texas , May 22, 2015 ... $58.4 million in 2014 and is estimated to reach $90.7 ... to 2019. Browse through the TOC of North ... and segments, with the help of various tables and figures. ... will receive 10% customization on this report.   ...
(Date:5/22/2015)... WASHINGTON , May 22, 2015  The ... certain diagnosed victims of mesothelioma get the best ... making certain individuals with this rare cancer caused ... the most up-to-date information related to treatment options ... information please call the Mesothelioma Victims Center anytime ...
(Date:5/22/2015)... May 22, 2015 Today, Rhodes Pharmaceuticals ... system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity ... Summer 2015. The announcement comes ... from the U.S. Food and Drug Administration (FDA). ... formulation of methylphenidate capsule with an onset of ...
Breaking Medicine Technology:North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6
... ... Jolla-, ... /PRNewswire-,FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a,biopharmaceutical company ... organization, today announced,that an agreement has been executed licensing classes of ...
... The Quigley,Corporation (Nasdaq: QGLY ) announced positive ... subsidiary, Quigley Pharma Inc., which was,conducted in chickens ... The compound was administered to chicks that had ... from the study indicated,that QR448(a) is efficacious against ...
Cached Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5
(Date:5/26/2015)... Carl W. Berk, M.D. and his ... Pinehurst, N.C. have launched a Balloon Sinuplasty website to ... sinusitis and the benefits of Balloon Sinuplasty. , The ... determine if someone is a good candidate for Balloon ... factors that can contribute to chronic nasal congestion. If ...
(Date:5/25/2015)... HAMMOND, La. (PRWEB) May 26, 2015 Author ... incredible number of people today are overweight, and many of ... their health. He also knows that most people don’t realize ... products, environmental hazards and man-made toxins that exist. ... general don’t realize exactly how serious tobacco is.” , In ...
(Date:5/25/2015)... Garden City, NY (PRWEB) May 26, 2015 ... Women (NAPW) honors Dr. Heather Stanley-Christian ... Woman of the Year Circle. She is recognized ... NAPW is the nation's leading networking organization exclusively ... and over 200 operating local chapters. , "I'm ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 World Patent ... products, launches the Big Little Party Table, a party ... perfect table that will suit their party needs. , ... of $646 billion this past year. Party Supply ... says Scott J. Cooper, CEO and Creative Director of ...
(Date:5/25/2015)... According to a recently published report ... hip external fixation market is driven by an increase ... advancements in infection prevention technologies. As the population ages, ... accounting for the largest total number of bone fixation ... accidents. As a result, the average selling price (ASP) ...
Breaking Medicine News(10 mins):Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2Health News:New Book Reveals ‘A Doctor’s Prescription for Longevity and Survival’ 2Health News:New Book Reveals ‘A Doctor’s Prescription for Longevity and Survival’ 3Health News:NAPW Inducts Dr. Heather Stanley-Christian, Systems Chair/Maternal Fetal Medicine at Stroger Hospital, into Its VIP Professional Woman of the Year Circle 2Health News:Party Time - Top Officials Get Excited About World Patent Marketing's New Party Invention For Entertainment 2Health News:Party Time - Top Officials Get Excited About World Patent Marketing's New Party Invention For Entertainment 3Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 2Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 3
... , THURSDAY, Nov. 4 (HealthDay News) -- Variations in ... HIV-infected people to remain healthy without having to take any ... efforts to develop new HIV treatments and vaccines, the study ... suppress viral replication and keep viral load at extremely low ...
... Behen HealthDay Reporter , THURSDAY, Nov. 4 (HealthDay ... may someday be able to boost your skills with the ... research suggests. In a study published in the Nov. ... Oxford University report that adults with normal math abilities were ...
... Researchers at Mayo Clinic ( http://www.mayoclinic.org/ ) have ... death in chronic lymphocytic leukemia (CLL) patients who ... in their blood compared to those who didn,t. ... including excerpts from an interview with Dr. Tait ...
... patient with a long head biceps (LHB) tendinopathy, which ... also have a shoulder problem and/or a rotator cuff ... overuse, inflammation or degeneration. Because of the variety ... a patient needs a thorough examination, including radiographic imaging ...
... WEDNESDAY, Nov. 3 (HealthDay News) -- A drug approved to ... of heart attacks and stroke when it,s used to stop ... surgery, a new study finds. Despite the nearly twofold ... vessels and cause heart attacks and stroke in those without ...
... the Agency for Science, Technology and Research (A*STAR) ... on human immunology and immune regulation. Under this ... A*STAR,s consortium, Singapore Immunology Network (SIgN), will jointly ... local and international aspiring scientists. Applications are open ...
Cached Medicine News:Health News:Protein Differences May Explain Long-Term HIV Control 2Health News:Electrical Brain Stimulation May Boost Math Skills 2Health News:Electrical Brain Stimulation May Boost Math Skills 3Health News:Insufficient vitamin D levels in CLL patients linked to cancer progression and death 2Health News:Insufficient vitamin D levels in CLL patients linked to cancer progression and death 3Health News:Hemophilia Drug Used Off-Label Raises Clot Risk 2Health News:Hemophilia Drug Used Off-Label Raises Clot Risk 3Health News:NTU and A*STAR launch joint Ph.D. research program in immunology 2
... The VersaPulse PowerSuite holmium laser combines ... for precise, virtually bloodless procedures. It ... urinary and gall bladder stones of ... multipurpose surgical tool. Because its laser ...
... quickly deliver up to 250 millijoules of ... single-pulse ablation. This type of high-energy pulse ... cleanest CO2 surgical laser available today. When ... independent adjustment of pulse energy and operating ...
... new CO2 laser system with intensities up ... an exclusive design for easy handling and ... is the leader in a new generation ... of Dekas laser devices, like safety and ...
... Laser hair removal for all ... Used for leg and ... Offers a large spot ... for fast treatment. An ...
Medicine Products: